Peter Hansen Perspectives on Development Aid Health Impact Assessment ASPHER/EAGHA Consultative...
-
Upload
barry-sullivan -
Category
Documents
-
view
212 -
download
0
Transcript of Peter Hansen Perspectives on Development Aid Health Impact Assessment ASPHER/EAGHA Consultative...
Peter Hansen
Perspectives on Development Aid Health Impact Assessment
ASPHER/EAGHA Consultative WorkshopBrussels, 6 February 2012
Consultative Workshop, ASPHER/EAGHABrussels, 6 February 2012
Principles that should underpin impact assessment
2
Central position of countries
What is the country’s impact?
To what extent do different factors, including development aid, contribute to that impact? How?
Impact is joint product of many causes, which operate through complex results chains
No cause is sufficient in itself to produce results
Contribution vs. attribution
Investments in impact assessment should recognize centrality of countries and explicitly focus on strengthening country ownership and capacities
Consultative Workshop, ASPHER/EAGHABrussels, 6 February 2012
GAVI’s M&E Framework and Strategy
3
Consultative Workshop, ASPHER/EAGHABrussels, 6 February 2012
Results framework
4
Consultative Workshop, ASPHER/EAGHABrussels, 6 February 2012
Full country evaluations
5
Build upon country-owned M&E platform
Contribute to strengthening M&E of national health strategies and existing review mechanisms
Country teams participate in all phases as full partners
Harmonise and align evaluation investments and activities across agencies where appropriate
Prospective study design
Conduct over 5 years, concurrent with implementation
Entire results framework covered, from inputs to impact
Indicators and data sources defined in advance
Consultative Workshop, ASPHER/EAGHABrussels, 6 February 2012
Full country evaluations
Baseline values documented from beginning, with data collection throughout
Focus on assessing country’s impact & identifying factors that meaningfully contribute to that impact; and how
Test assumptions in theory of change underpinning GAVI’s support to countries
Contextual factors that affect implementation—and positive and negative unintended consequences—explained and fully documented
Support ‘real time’ use of data and learning where possible at country and global levels
6
Consultative Workshop, ASPHER/EAGHABrussels, 6 February 2012
How do the full country evaluations relate to model-based estimates of impact?
Models focus on measuring impact of vaccination at country level
Country results, not GAVI results
Evaluations test assumptions of modeling exercises through direct measurement of specific endpoints in 5 countries
Evaluations provide evidence to assess robustness of assumptions and adjust assumptions as appropriate
Evaluations identify how interplay of range of factors contributes to the observed result
7
Consultative Workshop, ASPHER/EAGHABrussels, 6 February 2012
8